Physician profile
Timantha D Booth
NPI 1265748867
$646.26
in general payments reported to CMS, 2019-2025
15 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.52 · 2022: $49.86 · 2023: $105 · 2024: $195 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $204.93 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Dexcom, INC. | $111.21 | 2023-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $79.08 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Lilly USA, LLC | $44.37 | 2023-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $28.00 | 2024-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $23.44 | 2025 | The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.13 | 2024 | Xifaxan |
| Sumitomo Pharma America, INC. | $19.40 | 2023 | Gemtesa |
| Mylan Specialty L.P. | $18.99 | 2024 | Yupelri |
| Amgen INC. | $18.40 | 2024 | Repatha, Otezla |
| Astellas Pharma US INC | $17.66 | 2024 | Veozah |
| Blueprint Medicines Corporation | $16.38 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.35 | 2021 | |
| Philips North America LLC | $13.69 | 2024 | (Ck7) Extended Holter |
| Shield Therapeutics INC | $13.23 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timantha Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.